OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice
Giuseppe Cabibbo, Ciro Celsa, Lorenza Rimassa, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 957-966
Open Access | Times Cited: 18
Giuseppe Cabibbo, Ciro Celsa, Lorenza Rimassa, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 957-966
Open Access | Times Cited: 18
Showing 18 citing articles:
Hepatic artery infusion chemotherapy: A resurgence
A. Fung, Ksh Chok
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
A. Fung, Ksh Chok
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Hepatocellular carcinoma: Revising the surgical approach in light of the concept of multiparametric therapeutic hierarchy
Umberto Cillo, Enrico Gringeri, F. D’Amico, et al.
Digestive and Liver Disease (2025)
Closed Access
Umberto Cillo, Enrico Gringeri, F. D’Amico, et al.
Digestive and Liver Disease (2025)
Closed Access
Systemic therapy for child-pugh B patients with hepatocellular carcinoma
Kevin Mok, Olivia Chen, Johnny Yau, et al.
Expert Opinion on Emerging Drugs (2025), pp. 1-5
Closed Access
Kevin Mok, Olivia Chen, Johnny Yau, et al.
Expert Opinion on Emerging Drugs (2025), pp. 1-5
Closed Access
When Time Matters: Diagnosis of Percheron Stroke
Walid Sadki, Naïma Chtaou, Siham Bouchal, et al.
Cureus (2025)
Open Access
Walid Sadki, Naïma Chtaou, Siham Bouchal, et al.
Cureus (2025)
Open Access
Advancements in immunotherapy for hepatocellular carcinoma
S. Ascari, Rusi Chen, Caterina Vivaldi, et al.
Expert Review of Anticancer Therapy (2025) Vol. 25, Iss. 2, pp. 151-165
Closed Access
S. Ascari, Rusi Chen, Caterina Vivaldi, et al.
Expert Review of Anticancer Therapy (2025) Vol. 25, Iss. 2, pp. 151-165
Closed Access
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
Ziwei Yang, Tixin Han, Ruibin Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ziwei Yang, Tixin Han, Ruibin Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Highlighting recent achievements to advance more effective cancer immunotherapy
Beatrice Belmonte, Sheila Spada, Paola Allavena, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Beatrice Belmonte, Sheila Spada, Paola Allavena, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Precision surgery for hepatocellular carcinoma
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access
The Cardiotoxicity Risk of Immune Checkpoint Inhibitors Compared with Chemotherapy: A Systematic Review and Meta-analysis of Observational Studies
Yingying Zheng, Zishen Liu, Dong Chen, et al.
Cardiovascular Toxicology (2025)
Closed Access
Yingying Zheng, Zishen Liu, Dong Chen, et al.
Cardiovascular Toxicology (2025)
Closed Access
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?
Andrea Dalbeni, Filippo Cattazzo, L.A. Natola, et al.
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-10
Closed Access
Andrea Dalbeni, Filippo Cattazzo, L.A. Natola, et al.
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-10
Closed Access
Surveillance in HCC : Making the Most of What We Have Today
Marco Sanduzzi‐Zamparelli, Giuseppe Cabibbo
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Marco Sanduzzi‐Zamparelli, Giuseppe Cabibbo
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Hawthorn with “homology of medicine and food”: a review of anticancer effects and mechanisms
Ziying Zhou, Yi Nan, Xiangyang Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Ziying Zhou, Yi Nan, Xiangyang Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma
Stavros P. Papadakos, Elena Chatzikalil, Georgios Vakadaris, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2609-2609
Open Access | Times Cited: 2
Stavros P. Papadakos, Elena Chatzikalil, Georgios Vakadaris, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2609-2609
Open Access | Times Cited: 2
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma.
Bernardo Stefanini, Giulia Francesca Manfredi, Antonio D’Alessio, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 647-660
Open Access | Times Cited: 2
Bernardo Stefanini, Giulia Francesca Manfredi, Antonio D’Alessio, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 647-660
Open Access | Times Cited: 2
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma
Ezequiel Mauro, Manuel Rodríguez‐Perálvarez, Antonio D’Alessio, et al.
Liver International (2024)
Open Access | Times Cited: 2
Ezequiel Mauro, Manuel Rodríguez‐Perálvarez, Antonio D’Alessio, et al.
Liver International (2024)
Open Access | Times Cited: 2
Potential value and advances in research on bone mineral density (BMD) measurement in the auxiliary clinical assessment of hepatocellular carcinoma
Xudong Zhang, Lu Chen, Peipei Song, et al.
BioScience Trends (2024) Vol. 18, Iss. 4, pp. 398-403
Open Access | Times Cited: 1
Xudong Zhang, Lu Chen, Peipei Song, et al.
BioScience Trends (2024) Vol. 18, Iss. 4, pp. 398-403
Open Access | Times Cited: 1
Proteomics efforts for hepatocellular carcinoma drug development
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
The “shell game” after objective response in patients with advanced HCC treated with immunotherapy
Marco Sanduzzi‐Zamparelli, Giuseppe Cabibbo
Hepatology (2024)
Closed Access
Marco Sanduzzi‐Zamparelli, Giuseppe Cabibbo
Hepatology (2024)
Closed Access
